StockIQStockIQ.tech

IRADIMED CORPORATION (IRMD) Stock Analysis

--

Free AI-powered analysis and research for IRADIMED CORPORATION stock

Sector: Healthcare

Full IRMD report

IRADIMED CORPORATION (IRMD) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze IRMD Now β†’

πŸ“° Latest Update

IRadimed (IRMD) Stock Drops After Q3 Earnings Fail To Clear High Bar

IRadimed (IRMD) saw its stock drop approximately 11% following its Q3 2026 earnings report, despite achieving record revenue of US$24.2 million and basic earnings per share of US$0.51. The decline is attributed to high investor expectations rather than a collapse in performance, as the company reported a 14% revenue increase year-over-year and improved net profit margins. Concerns remain regarding the impact of rising manufacturing costs on profitability amidst a new product rollout.

Read full article β†’

History

People also watch

LLY
Eli Lilly and Company
--
ZTS
Zoetis Inc.
--
UNH
UnitedHealth Group Inc.
--
ABUS
Arbutus Biopharma Corporation
--
AQST
Aquestive Therapeutics, Inc.
--